Definitive Diagnostics
Definitive Diagnostics
  • Home
  • About Us
  • Results
  • Team
  • In the News
  • Contact
  • More
    • Home
    • About Us
    • Results
    • Team
    • In the News
    • Contact
  • Home
  • About Us
  • Results
  • Team
  • In the News
  • Contact

RECENT NEWS

Definitive Diagnostics Wins NYBio Pitchfest

Independent Peer Review Validates Definitive Diagnostics’ Platform

Independent Peer Review Validates Definitive Diagnostics’ Platform

October 30, 2025 

Definitive Diagnostics Wins NYBio Pitchfest, Hosted by Cooley

Highlighting Strong Investor and Industry Validation


The NYBio Pitchfest is a competitive showcase of early-stage life sciences companies to present to experienced biotech investors, industry leaders, and strategic partners focused on identifying high-potential innovations in healthcare. 

Independent Peer Review Validates Definitive Diagnostics’ Platform

Independent Peer Review Validates Definitive Diagnostics’ Platform

Independent Peer Review Validates Definitive Diagnostics’ Platform

October 14, 2025

Protein-Based Liquid Biopsy Platform from Definitive Diagnostics Validated Through Peer-Reviewed Biomedicines Publication 


Protein- and immune-based biomarker approach, leveraging abundant, biologically meaningful signals rather than scarce ctDNA fragments, addressing known limitations of DNA-based liquid biopsies in early disease... 

Definitive Diagnostics Publishes First Research Article on medRxiv

Definitive Diagnostics Publishes First Research Article on medRxiv

Definitive Diagnostics Publishes First Research Article on medRxiv

May 9, 2025

Definitive Diagnostics’ Proteomics Cancer Test Validated in medRxiv Study 


 

Definitive Diagnostics announced the publication of its first scientific article, detailing a protein-based liquid biopsy platform for multi-cancer detection. The study reports strong diagnostic performance across breast, lung, colorectal, ovarian, and pancreatic cancers, including robust detection of early-stage disease and high tissue-of-origin accuracy. 

Named Healthcare Grand Prize Winner - NYU Entrepreneur Challenge

Definitive Diagnostics Publishes First Research Article on medRxiv

Definitive Diagnostics Publishes First Research Article on medRxiv

May 2, 2025

 Definitive Diagnostics Wins Healthcare Grand Prize at the 2025 NYU/Berkley Center's "Entrepreneurs Challenge"


 

The NYU Entrepreneurs Challenge is a highly competitive startup competition that awards early-stage companies with strong innovation, commercialization potential, and real-world impact. 

Copyright © 2025 Definitive Diagnostics, Inc.

Powered by

  • Home
  • About Us
  • Results
  • Contact

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept